Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

9.79USD
25 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$9.79
Open
$9.73
Day's High
$10.11
Day's Low
$9.59
Volume
35,884
Avg. Vol
16,177
52-wk High
$10.25
52-wk Low
$4.11

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 4.35 -0.682
FY 2018 Dec '18 7.58 -0.100
Sep '18 3.42 -0.421
Jun '18 2.39 -0.989
Mar '18 2.37 -0.654
FY 2017 Dec '17 2.02 -0.854
Sep '17 3.30 -1.513
Jun '17 3.76 -0.541
Mar '17 3.92 -0.663
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 5 3.12 4.46 2.10 --
Quarter Ending Sep-19 5 3.07 4.57 1.70 --
Year Ending Dec-19 5 13.72 18.06 9.80 3.33
Year Ending Dec-20 5 11.55 18.88 2.50 --
Earnings (per share)
Quarter Ending Jun-19 5 -0.68 -0.56 -0.81 -0.75
Quarter Ending Sep-19 5 -0.61 -0.54 -0.70 -0.78
Year Ending Dec-19 4 -2.58 -2.22 -2.90 -2.12
Year Ending Dec-20 5 -2.46 -2.18 -2.99 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.29 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta 1.47 1.08 0.87
Price to Sales (TTM) -- 49.50 8.44
Price to Book (MRQ) 0.71 10.13 5.27
Price to Tangible Book (MRQ) 0.71 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 31.80 3.72 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.03 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 49.04 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.23 75.31 48.19
EPS (TTM) vs TTM 1 Yr. Ago 4.79 -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate 25.26 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 25.42 3.57 2.98
LT Debt to Equity (MRQ) 0.00 18.62 11.35
Total Debt to Equity (MRQ) 0.00 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 52.36
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -- -184.92 5.62
Operating Margin - 5 Yr. Avg. -- -127.40 8.00
Pre-Tax Margin (TTM) -- -175.61 4.64
Pre-Tax Margin - 5 Yr. Avg. -- -133.19 8.28
Net Profit Margin (TTM) -- -182.33 1.37
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,652,641 819,624,671
Net Income/Employee (TTM) -1,102,105 513,407 92,776,869
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.87 6.37 10.65
Return on Assets - 5 Yr. Avg. -52.08 5.47 11.77
Return on Investment (TTM) -41.68 8.90 13.82
Return on Investment - 5 Yr. Avg. -55.12 6.78 15.32
Return on Equity (TTM) -41.68 10.04 15.24
Return on Equity - 5 Yr. Avg. -55.12 8.36 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 0.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arcturus Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.30%
# of Holders: 24
Total Shares Held: 1,861,996
3 Mo. Net Change: 292,754
# New Positions: 5
# Closed Positions: 5
# Increased Positions: 8
# Reduced Positions: 9
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.